| 臺大學術典藏 |
2022-04-28T08:06:32Z |
The law of Yin and Yang for controlled drugs ecosystem: Maximal analgesia with minimal abuse
|
Sun W.-Z.; Hsieh Y.-J.; Lin C.-S.; YEUR-HUR LAI; Chien S.-C.; Wang C.-W.; Hsieh R.-K.; Taiwan Pain Forum |
| 臺大學術典藏 |
2022-01-24T09:32:34Z |
Gene rearrangement of cutaneous T-cell lymphoma.
|
Fan F.S.; Lin S.H.; Tzeng C.H.; Chuang M.W.; Yang J.H.; Liu J.H.; Hsieh R.K.; CHUN-JEN LIU; Liu J.M.; Chen M.S. |
| 臺大學術典藏 |
2022-01-24T09:32:34Z |
Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy
|
Tzeng C.-H.; Chen P.-M.; Chuang M.-W.; Liu J.-H.; Hsieh R.-K.; CHUN-JEN LIU; Fan S.; Chen K.Y.; Yung C.-H.; Wang S.-Y.; Chau W.-K.; Ching K.-N. |
| 臺大學術典藏 |
2022-01-24T09:32:33Z |
Remission induction of ANLL with low dose cytosine arabinoside combined with retinoic acid.
|
Chen P.M.; Hsieh R.K.; Chuang M.W.; Liu J.H.; Fan S.; CHUN-JEN LIU; Tzeng C.H. |
| 臺大學術典藏 |
2022-01-24T09:32:33Z |
Complications of bone marrow transplantation in Chinese.
|
Chen P.M.; Fan S.; CHUN-JEN LIU; Hsieh R.K.; Liu J.H.; Chuang M.W.; Liu R.S.; Tzeng C.H. |
| 臺大學術典藏 |
2021-09-01T02:02:42Z |
Weekly CAF chemotherapy for advanced breast cancer patients
|
Hwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:19Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.; Yeh K.H.; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:10Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; Yeh K.H.; Kao W.Y.; Chen L.T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:08Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; Yeh K.-H.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-11T03:46:52Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y. |
| 臺大學術典藏 |
2021-08-11T03:46:50Z |
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting
|
Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN; Chao T.-Y. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Hong R.-L.; CHING-HUNG LIN; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-05-03T02:20:56Z |
Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy—a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines
|
Yu S.; Burke T.A.; Chan A.; Kim H.-K.; Hsieh R.K.; Hu X.; JIN-TUNG LIANG; Ba?os A.; Spiteri C.; Keefe D.M.K. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Ruey-Long Hong;Lin C.-H.;Chao T.-Y.;Kao W.-Y.;Wang C.-H.;Hsieh R.K.;Hwang W.-S.; RUEY-LONG HONG; Lin C.-H.; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-03-05T06:07:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; MING-CHU CHANG; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-02-05T06:29:30Z |
Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis
|
Lim K.-H.; Lin H.-C.; Chen C.G.S.; Wang W.-T.; Chang Y.-C.; Chiang Y.-H.; Lin C.-S.; Su N.-W.; Su Y.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU |
| 臺大學術典藏 |
2021-02-05T06:29:29Z |
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis
|
Lim K.-H.; Chang Y.-C.; Gon-Shen Chen C.; Lin H.-C.; Wang W.-T.; Chiang Y.-H.; Cheng H.-I.; Su N.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU |
| 臺大學術典藏 |
2021-02-05T06:29:22Z |
Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population
|
Chiang Y.-H.;Chang Y.-C.;Lin H.-C.;Huang L.;Cheng C.-C.;Wang W.-T.;Cheng H.-I.;Su N.-W.;Chen C.G.;Lin J.;Chang Y.-F.;Chang M.-C.;Hsieh R.-K.;Wen-Chien Chou;Lim K.-H.;Kuo Y.-Y.; Chiang Y.-H.; Chang Y.-C.; Lin H.-C.; Huang L.; Cheng C.-C.; Wang W.-T.; Cheng H.-I.; Su N.-W.; Chen C.G.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; WEN-CHIEN CHOU; Lim K.-H.; Kuo Y.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.;Kun-Huei Yeh;Chang C.J.;Chen L.T.;Chao T.Y.;Wu M.F.;Chang C.S.;Chang J.Y.;Chung C.Y.;Kao W.Y.;Hsieh R.K.;Cheng A.L.; Chao Y.; KUN-HUEI YEH; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao Y.;Li C.P.;Chao T.Y.;Su W.C.;Hsieh R.K.;Wu M.F.;Kun-Huei Yeh;Kao W.Y.;Chen L.T.;Cheng A.L.; Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH; Kao W.Y.; Chen L.T.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:41Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.;Chao Y.;Hsieh R.-K.;Cheng A.-L.;Chen P.-M.;Chiou T.-J.;Chao T.-Y.;Kun-Huei Yeh;Chen L.-T.;Whang-Peng J.; Chen J.-S.; Chao Y.; Hsieh R.-K.; Cheng A.-L.; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial
|
Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need
|
Rau K.-M.;Rau K.-M.;Shun S.-C.;Chiou T.-J.;Lu C.-H.;Lu C.-H.;Ko W.-H.;Ko W.-H.;Lee M.-Y.;Huang W.-T.;Kun-Huei Yeh;Chang C.-S.;Chang C.-S.;Hsieh R.-K.; Rau K.-M.; Rau K.-M.; Shun S.-C.; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH; Chang C.-S.; Chang C.-S.; Hsieh R.-K. |
